A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | MicrobiomeTrials← Back to trialsNCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-27Est. Completion: 2028-06-30
Enrollment target: 960 participants Locations- Research Network Arizona / Retina Macula Institute of Arizona, Scottsdale, Arizona, United States
- Retina Partners of Northwest Arkansas, PLLC, Springdale, Arkansas, United States
- Global Research Management, Inc., Glendale, California, United States
- Retinal Consultants Medical Group (Site 024), Modesto, California, United States
- Retina Consultants of Southern California (Site 043), Redlands, California, United States
- Retinal Consultants Medical Group (Site 020), Sacramento, California, United States
- Retinal Consultants Medical Group (Site 022), Sacramento, California, United States
- Retina Group of Florida (Site 070), Fort Lauderdale, Florida, United States
- Vitreo Retinal Associates, Gainesville, Florida, United States
- Fort Lauderdale Eye Institute (Site 042), Plantation, Florida, United States
- Retina Vitreous Associates of Florida (Site 049), St. Petersburg, Florida, United States
- Retina Associates of Florida, LLC, Tampa, Florida, United States
- Retina Vitreous Associates of Florida, Tampa, Florida, United States
- Illinois Retina Associates, Oak Park, Illinois, United States
Other microbiome trials you might be interested in
Retinitis Pigmentosa
Retinitis pigmentosa (RP) is an inherited retinal degeneration caused by one of several mistakes in the genetic code. Su…
Davis, United StatesEst. completion May 2029
Geographic AtrophyAge-Related Macular Degeneration
Age-related macular degeneration (AMD) is the abnormal growth of new blood vessels in the light-sensitive tissue at the …
Carmel, United StatesEst. completion Oct 2029
Associated Vitreoretinal and Uveitis Consultants, Carmel, Indiana, United StatesCumberland Valley Retina Consultants (Site 007), Hagerstown, Maryland, United StatesFoundation for Vision Research (Site 073), Grand Rapids, Michigan, United StatesMississippi Retina Associates (Site 084), Madison, Mississippi, United Statesong Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY (Site 105), Hauppauge, New York, United StatesRetina Vitreous Surgeons of CNY, PC (Site 033), Liverpool, New York, United StatesPiedmont Retina Specialists - Winston-Salem, Winston-Salem, North Carolina, United StatesTulsa Retina Consultants, Tulsa, Oklahoma, United StatesRetina Northwest, PC, Portland, Oregon, United StatesEyeHealth Northwest, Portland, Oregon, United StatesPalmetto Retina Center, Aiken, South Carolina, United StatesCharleston Neuroscience Institute - Bluffton (Site 124), Bluffton, South Carolina, United StatesCharleston Neuroscience Institute (Site 104), Charleston, South Carolina, United StatesCharles Retina Institute, Germantown, Tennessee, United StatesRetina Research Institute of Texas (Site 010), Abilene, Texas, United StatesSouthwest Retina Specialists, Amarillo, Texas, United StatesTexas Retina Associates, Arlington, Texas, United StatesAustin Research Center for Retina, Austin, Texas, United StatesAustin Retina Associates (Site 012), Austin, Texas, United StatesRetina & Vitreous of Texas, Bellaire, Texas, United StatesTexas Retina Associates, Dallas, Texas, United StatesTexas Retina (Site 037), Plano, Texas, United StatesRetina Center of Texas, Southlake, Texas, United StatesRetina Consultants of Texas (Site 014), The Woodlands, Texas, United StatesStrategic Clinical Research Group, Weatherford, Texas, United StatesRetina Associates of Utah, Salt Lake City, Utah, United StatesPiedmont Eye Center (Site 054), Lynchburg, Virginia, United StatesPacific Northwest Retina (Site 112), Burlington, Washington, United StatesRecruiting
Age-related Macular Degeneration (AMD)
Age-related macular degeneration (AMD) is the leading cause of blindness after 50 years in industrialized countries, com…
Amiens, FranceEst. completion Jun 2026